ReviewFrontiers in drug safety and regulation2024

Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies.

Chinenye Ugoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.